相关实验视频
Updated: Jun 26, 2025
05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.0K
安全网医院风险模型在描述肺癌风险时显示出更强的,特定于人群的适用性
Adriana A Rodriguez Alvarez1, Benjamin Crosby1, Sarah Singh2
1Department of Clinical Research, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
Translational cancer research
|May 13, 2024
概括
为安全网医院 (SNH) 种群开发的新型肺癌 (LC) 风险模型比PLCO模型具有更高的特异性. 这凸显了代表性数据在开发有效的LC查工具方面的重要性.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 生物统计学 生物统计学
背景情况:
- 个性化肺癌 (LC) 风险分层可以提高查效率.
- 来自高加索人口的前列腺,肺,结肠直肠和卵巢癌查试验 (PLCO) 模型可能不适合不同人群.
- 现有的LC风险模型在医院安全网 (SNH) 设置中的有效性在很大程度上是未知的.
研究的目的:
- 开发和评估一个针对SNH群体量身定制的新型LC风险分层模型.
- 为了在SNH环境中比较SNH特定模型与已建立的PLCO模型的性能.
主要方法:
- 分析了2015-2019年间在SNH查LC的896名患者的回顾性数据集.
- 关键变量包括年龄,性别,种族,BMI,吸烟史,癌症史,COPD和肺气.
- 使用SNH和PLCO模型计算LC风险得分,并比较性能指标 (灵敏度,特异性).
主要成果:
- 该SNH人口主要包括非洲裔美国人 (53.5%),目前吸烟者 (69.9%) 和肺气患者 (70.1%).
- 与PLCO模型 (26.1%) 相比,SNH模型在描述LC风险方面表现出明显更高的特异性 (96.8%).
- 在SNH模型 (P<0.001) 中,肺气与LC风险有很强的关联,而种族没有显著的关系.
结论:
- 开发的SNH模型在SNH种群中对肺癌风险评估具有优越的特异性.
- 这项研究强调了对代表性样本数据的关键需求,以开发针对不同患者群体准确的风险分层模型.
相关概念视频
01:25Statistical Methods for Analyzing Epidemiological Data
363
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
363
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
01:12Relative Risk
156
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
156
01:12Hazard Ratio
115
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
115